$153.97
1.030.67%
At close: -
$153.97
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Virtus Inv Analyst Ratings and Price Targets | NYSE:VRTS | Benzinga
Virtus Investment Partners Inc has a consensus price target of $206.4 based on the ratings of 5 analysts. The high is $260 issued by Piper Sandler on March 27, 2023. The low is $158 issued by TD Cowen on April 9, 2025. The 3 most-recent analyst ratings were released by TD Cowen, Piper Sandler, and Morgan Stanley on April 9, 2025, April 8, 2025, and February 6, 2025, respectively. With an average price target of $190.67 between TD Cowen, Piper Sandler, and Morgan Stanley, there's an implied 23.83% upside for Virtus Investment Partners Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Piper Sandler
Morgan Stanley
Barclays
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Virtus Inv
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/09/2025 | Buy Now | 2.62% | TD Cowen | Bill Kirk47% | $220 → $158 | Maintains | Hold | Get Alert |
| 04/08/2025 | Buy Now | 40.29% | Piper Sandler | Crispin Love49% | $252 → $216 | Maintains | Overweight | Get Alert |
| 02/06/2025 | Buy Now | 28.6% | Morgan Stanley | Michael Cyprys70% | $211 → $198 | Maintains | Underweight | Get Alert |
| 02/03/2025 | Buy Now | 29.9% | Barclays | Benjamin Budish74% | $221 → $200 | Maintains | Underweight | Get Alert |
| 01/21/2025 | Buy Now | 67.57% | Piper Sandler | Crispin Love49% | $274 → $258 | Maintains | Overweight | Get Alert |
| 01/17/2025 | Buy Now | 43.53% | Barclays | Benjamin Budish74% | $239 → $221 | Maintains | Underweight | Get Alert |
| 12/20/2024 | Buy Now | 48.08% | Morgan Stanley | Michael Cyprys70% | $224 → $228 | Maintains | Underweight | Get Alert |
| 12/09/2024 | Buy Now | 55.23% | Barclays | Benjamin Budish74% | $212 → $239 | Maintains | Underweight | Get Alert |
| 11/27/2024 | Buy Now | 77.96% | Piper Sandler | Crispin Love49% | $264 → $274 | Maintains | Overweight | Get Alert |
| 10/18/2024 | Buy Now | 40.94% | Morgan Stanley | Michael Cyprys70% | $208 → $217 | Maintains | Underweight | Get Alert |
| 08/27/2024 | Buy Now | 33.79% | Barclays | Benjamin Budish74% | → $206 | Initiates | → Underweight | Get Alert |
| 07/29/2024 | Buy Now | 35.09% | Morgan Stanley | Michael Cyprys70% | $213 → $208 | Maintains | Underweight | Get Alert |
| 07/10/2024 | Buy Now | 71.46% | Piper Sandler | Crispin Love49% | $267 → $264 | Maintains | Overweight | Get Alert |
| 07/08/2024 | Buy Now | 60.42% | TD Cowen | Bill Kirk47% | $250 → $247 | Maintains | Hold | Get Alert |
| 05/29/2024 | Buy Now | 73.41% | Piper Sandler | Crispin Love49% | $265 → $267 | Maintains | Overweight | Get Alert |
| 04/29/2024 | Buy Now | 62.37% | TD Cowen | Bill Kirk47% | $245 → $250 | Maintains | Hold | Get Alert |
| 04/29/2024 | Buy Now | 72.11% | Piper Sandler | Crispin Love49% | $275 → $265 | Maintains | Overweight | Get Alert |
| 04/17/2024 | Buy Now | 45.48% | Morgan Stanley | Michael Cyprys70% | $211 → $224 | Maintains | Underweight | Get Alert |
| 04/08/2024 | Buy Now | 71.46% | TD Cowen | Bill Kirk47% | $285 → $264 | Downgrade | Buy → Hold | Get Alert |
| 03/27/2024 | Buy Now | 78.61% | Piper Sandler | Crispin Love49% | $264 → $275 | Maintains | Overweight | Get Alert |
| 01/19/2024 | Buy Now | 29.25% | Morgan Stanley | Michael Cyprys70% | $170 → $199 | Maintains | Underweight | Get Alert |
| 01/04/2024 | Buy Now | 87.7% | TD Cowen | Bill Kirk47% | → $289 | Initiates | → Outperform | Get Alert |
| 12/20/2023 | Buy Now | 71.46% | Piper Sandler | Crispin Love49% | → $264 | Assumes | → Overweight | Get Alert |
| 10/30/2023 | Buy Now | 10.41% | Morgan Stanley | Michael Cyprys70% | $163 → $170 | Maintains | Underweight | Get Alert |
| 10/23/2023 | Buy Now | 5.86% | Morgan Stanley | Michael Cyprys70% | $162 → $163 | Maintains | Underweight | Get Alert |
| 10/06/2023 | Buy Now | 5.22% | Morgan Stanley | Michael Cyprys70% | $173 → $162 | Maintains | Underweight | Get Alert |
| 08/01/2023 | Buy Now | 12.36% | Morgan Stanley | Michael Cyprys70% | $159 → $173 | Maintains | Underweight | Get Alert |
| 07/31/2023 | Buy Now | 12.36% | Morgan Stanley | Michael Cyprys70% | $159 → $173 | Maintains | Underweight | Get Alert |
| 07/25/2023 | Buy Now | 3.27% | Morgan Stanley | Michael Cyprys70% | $153 → $159 | Maintains | Underweight | Get Alert |
| 07/12/2023 | Buy Now | -0.63% | Morgan Stanley | Michael Cyprys70% | $150 → $153 | Maintains | Underweight | Get Alert |
| 03/27/2023 | Buy Now | 68.86% | Piper Sandler | Sumeet Mody86% | $248 → $260 | Upgrade | Neutral → Overweight | Get Alert |
| 02/06/2023 | Buy Now | — | Piper Sandler | Sumeet Mody86% | — | Downgrade | Overweight → Neutral | Get Alert |
| 01/19/2023 | Buy Now | -2.58% | Morgan Stanley | Michael Cyprys70% | $134 → $150 | Maintains | Underweight | Get Alert |
| 10/28/2022 | Buy Now | -12.97% | Morgan Stanley | Michael Cyprys70% | $142 → $134 | Maintains | Underweight | Get Alert |
| 10/03/2022 | Buy Now | 1.32% | Morgan Stanley | Michael Cyprys70% | $158 → $156 | Maintains | Underweight | Get Alert |
| 08/01/2022 | Buy Now | 2.62% | Morgan Stanley | Michael Cyprys70% | $159 → $158 | Maintains | Underweight | Get Alert |
| 07/25/2022 | Buy Now | 3.27% | Morgan Stanley | Michael Cyprys70% | $155 → $159 | Maintains | Underweight | Get Alert |
| 07/15/2022 | Buy Now | 74.06% | Piper Sandler | Sumeet Mody86% | $289 → $268 | Maintains | Overweight | Get Alert |
| 06/30/2022 | Buy Now | 0.67% | Morgan Stanley | Michael Cyprys70% | $203 → $155 | Maintains | Underweight | Get Alert |
| 06/16/2022 | Buy Now | 87.7% | Piper Sandler | Sumeet Mody86% | $300 → $289 | Maintains | Overweight | Get Alert |
| 05/18/2022 | Buy Now | 94.84% | Piper Sandler | Sumeet Mody86% | $325 → $300 | Maintains | Overweight | Get Alert |
| 05/02/2022 | Buy Now | 31.84% | Morgan Stanley | Michael Cyprys70% | $221 → $203 | Maintains | Underweight | Get Alert |
| 05/02/2022 | Buy Now | 111.08% | Piper Sandler | Sumeet Mody86% | $375 → $325 | Maintains | Overweight | Get Alert |
| 04/26/2022 | Buy Now | 43.53% | Morgan Stanley | Michael Cyprys70% | $240 → $221 | Maintains | Underweight | Get Alert |
FAQ
What is the target price for Virtus Inv (VRTS) stock?
The latest price target for Virtus Inv (NYSE:VRTS) was reported by TD Cowen on April 9, 2025. The analyst firm set a price target for $158.00 expecting VRTS to rise to within 12 months (a possible 2.62% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Virtus Inv (VRTS)?
The latest analyst rating for Virtus Inv (NYSE:VRTS) was provided by TD Cowen, and Virtus Inv maintained their hold rating.
When was the last upgrade for Virtus Inv (VRTS)?
The last upgrade for Virtus Investment Partners Inc happened on March 27, 2023 when Piper Sandler raised their price target to $260. Piper Sandler previously had a neutral for Virtus Investment Partners Inc.
When was the last downgrade for Virtus Inv (VRTS)?
The last downgrade for Virtus Investment Partners Inc happened on April 8, 2024 when TD Cowen changed their price target from $285 to $264 for Virtus Investment Partners Inc.
When is the next analyst rating going to be posted or updated for Virtus Inv (VRTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Virtus Inv, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Virtus Inv was filed on April 9, 2025 so you should expect the next rating to be made available sometime around April 9, 2026.
Is the Analyst Rating Virtus Inv (VRTS) correct?
While ratings are subjective and will change, the latest Virtus Inv (VRTS) rating was a maintained with a price target of $220.00 to $158.00. The current price Virtus Inv (VRTS) is trading at is $153.97, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.